Sight Sciences First Quarter 2025 Earnings: Beats Expectations

Simply Wall St · 5d ago

Sight Sciences (NASDAQ:SGHT) First Quarter 2025 Results

Key Financial Results

  • Revenue: US$17.5m (down 9.1% from 1Q 2024).
  • Net loss: US$14.2m (loss narrowed by 13% from 1Q 2024).
  • US$0.28 loss per share (improved from US$0.33 loss in 1Q 2024).
earnings-and-revenue-growth
NasdaqGS:SGHT Earnings and Revenue Growth May 10th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Sight Sciences Revenues and Earnings Beat Expectations

Revenue exceeded analyst estimates by 6.0%. Earnings per share (EPS) also surpassed analyst estimates by 4.9%.

Looking ahead, revenue is forecast to grow 6.7% p.a. on average during the next 3 years, compared to a 8.1% growth forecast for the Medical Equipment industry in the US.

Performance of the American Medical Equipment industry.

The company's share price is broadly unchanged from a week ago.

Risk Analysis

You should always think about risks. Case in point, we've spotted 3 warning signs for Sight Sciences you should be aware of.